BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:04 PM
 | 
Mar 30, 2009
 |  BC Extra  |  Company News

FDA approves Novartis' Afinitor

FDA approved an NDA from Novartis (NYSE:NVS; SIX:NOVN) for Afinitor everolimus ( RAD001) to treat advanced kidney cancer...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >